Torreya
John Bradley is a seasoned financial professional currently serving as Managing Director at Torreya Partners LLC since April 2012, after previously holding the position of VP at Drexel Burnham. As Founder and President of the NYSE firm Bradley-Hummel & Co, John has successfully founded, seeded, and financed over 60 companies across various industries, including notable names such as Watson Pharmaceuticals and Teva. With 25 years of experience managing High Net Worth investments amounting to $800 million, John also acts as Principal at Torreya-EM since 2009, further showcasing a robust track record in financial management and entrepreneurship.
Torreya
Torreya, a Stifel Company, is a global investment banking boutique serving companies in the life sciences industry. Since its inception in 2007, the firm has closed over $100 billion worth of deals in nearly 250 assignments spanning branded pharmaceutical, biotechnology, generic pharmaceutical, and life sciences companies. Our partners are senior industry bankers and executives, with deep experience, knowledge, and networks. We are a partner of choice for companies seeking discreet, conflict-free and knowledgeable advice on M&A, capital markets, licensing and asset sale transactions.